Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area.

Canivell S, Mata-Cases M, Vlacho B, Gratacòs M, Real J, Mauricio D, Franch-Nadal J.

J Diabetes Res. 2019 Nov 11;2019:2018374. doi: 10.1155/2019/2018374. eCollection 2019.

2.

Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia.

Franch-Nadal J, Mata-Cases M, Ortega E, Real J, Gratacòs M, Vlacho B, Vallés JA, Mauricio D.

J Clin Med. 2019 Sep 5;8(9). pii: E1389. doi: 10.3390/jcm8091389.

3.

Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes:real-world evidence from a Mediterranean area.

Mata-Cases M, Franch-Nadal J, Ortega E, Real J, Gratacòs M, Vlacho B, Mauricio D.

Curr Med Res Opin. 2019 Oct;35(10):1735-1744. doi: 10.1080/03007995.2019.1618806. Epub 2019 Jun 17.

PMID:
31081693
4.

Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting.

Canivell S, Mata-Cases M, Real J, Franch-Nadal J, Vlacho B, Khunti K, Gratacòs M, Mauricio D.

Diabetes Obes Metab. 2019 Jun;21(6):1373-1380. doi: 10.1111/dom.13663. Epub 2019 Mar 19.

PMID:
30756446
5.

INTEGRA study protocol: primary care intervention in type 2 diabetes patients with poor glycaemic control.

Molló À, Berenguera A, Rubinat E, Vlacho B, Mata M, Franch J, Bolíbar B, Mauricio D.

BMC Fam Pract. 2019 Feb 7;20(1):25. doi: 10.1186/s12875-019-0916-9.

6.

Randomized placebo-controlled clinical trial on efficacy and safety of topical 10% Potassium hydroxide for molluscum contagiosum treatment in children.

Giner-Soriano M, Teixidó C, Marsal JR, Díez O, Pera H, Vlacho B, Morros R; working group for the clinical trial IJG-KOH-2014.

J Dermatolog Treat. 2019 Dec;30(8):750-756. doi: 10.1080/09546634.2019.1573305. Epub 2019 Feb 3.

PMID:
30668179
7.

Glycaemic control and treatment of type 2 diabetes in adults aged 75 years or older.

Rodriguez-Poncelas A, Barrot-de la-Puente J, Coll de Tuero G, López-Arpí C, Vlacho B, Lopéz-Simarro F, Mundet Tudurí X, Franch-Nadal J.

Int J Clin Pract. 2018 Mar;72(3):e13075. doi: 10.1111/ijcp.13075. Epub 2018 Mar 7.

PMID:
29512235
8.

Dabigatran and vitamin K antagonists' use in naïve patients with non-valvular atrial fibrillation: a cross-sectional study of primary care-based electronic health records.

Vlacho B, Giner-Soriano M, Zabaleta-Del-Olmo E, Roso-Llorach A, García-Sangenís A, Morros-Pedrós R.

Eur J Clin Pharmacol. 2017 Oct;73(10):1323-1330. doi: 10.1007/s00228-017-2305-4. Epub 2017 Jul 19.

PMID:
28725983
9.

Safety of the reuse of needles for subcutaneous insulin injection: A systematic review and meta-analysis.

Zabaleta-Del-Olmo E, Vlacho B, Jodar-Fernández L, Urpí-Fernández AM, Lumillo-Gutiérrez I, Agudo-Ugena J, Morros-Pedrós R, Violán C.

Int J Nurs Stud. 2016 Aug;60:121-32. doi: 10.1016/j.ijnurstu.2016.04.010. Epub 2016 Apr 27. Review.

PMID:
27297374

Supplemental Content

Loading ...
Support Center